Heffernan Michael Thomas insider trades
Heffernan Michael Thomas has filed 29 Form 4s with the SEC that we hold, for Collegium Pharmaceutical, INC (COLL) (Director), Biohaven Ltd. (BHVN) (Director), Trevi Therapeutics, Inc. (TRVI) (Director) and Avalo Therapeutics, Inc. (AVTX) (Director), among 7 companies in all. Across all of them we count 0 purchases worth $0 and 12 sales worth $7.3M reported on Form 4. In the last 12 months: 0 purchases ($0) and 3 sales ($594.2K). The largest single trade was a sale of 161,687 shares of Collegium Pharmaceutical, INC worth $3.6M, dated 2022-12-13. Of 3 sales filed since we began reading the 10b5-1 checkbox, 3 (100%) were marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2021-12-22 and the latest 2026-09-17.
Collegium Pharmaceutical, INC (COLL)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2022-12-12 | S, sale reported on Form 4 | 27,920 | $614.5K | 2022-12-14 | SEC |
| 2022-12-13 | S, sale reported on Form 4 | 161,687 | $3.6M | 2022-12-14 | SEC |
| 2022-12-19 | S, sale reported on Form 4 | 3,606 | $83.1K | 2022-12-21 | SEC |
| 2022-12-20 | S, sale reported on Form 4 | 33,758 | $779.1K | 2022-12-21 | SEC |
| 2022-12-21 | S, sale reported on Form 4 | 46,600 | $1.1M | 2022-12-21 | SEC |
| 2022-12-22 | S, sale reported on Form 4 | 237 | $5.5K | 2022-12-27 | SEC |
| 2022-12-23 | S, sale reported on Form 4 | 4,989 | $114.7K | 2022-12-27 | SEC |
| 2022-12-27 | S, sale reported on Form 4 | 15,995 | $378.0K | 2022-12-27 | SEC |
| 2022-12-27 | S, sale reported on Form 4 | 3,820 | $92.3K | 2022-12-27 | SEC |
Biohaven Ltd. (BHVN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Trevi Therapeutics, Inc. (TRVI)
Avalo Therapeutics, Inc. (AVTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
BHVN (BHVN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Synlogic, INC. (SYBX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
enGene Therapeutics Inc. (ENGN)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1448914) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
